Pricing Log in Create free account

Neurogene Inc. (NGNE) vs Ovid Therapeutics (OVID)

Neurogene Inc. and Ovid Therapeutics are both Biotechnology companies. Neurogene Inc. and Ovid Therapeutics are of similar size ($513.3M and $503.9M). Neurogene Inc. has the higher net margin (0.00% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 14 metrics below, Ovid Therapeutics leads on 8 and Neurogene Inc. on 6.

Valuation

Metric NGNE OVID Biotechnology median
P/E n/m n/m 10.60
P/S n/m 72.14 9.40
P/B 2.63 2.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 58.65 9.02
Earnings yield (19.89%) (7.85%) (32.88%)
Free cash flow yield (15.38%) (9.69%) (23.13%)

Profitability

Metric NGNE OVID Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (742.97%) 0.00%
Net margin 0.00% (439.11%) 0.00%
Free cash flow margin 0.00% (697.30%) 0.00%
Return on equity (45.32%) (25.97%) (51.96%)
Return on assets (41.02%) (22.30%) (46.06%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric NGNE OVID Biotechnology median
Revenue growth (TTM) — 1,333.39% 6.76%
EPS growth (last fiscal year) 0.93% 37.84% 29.88%
Revenue growth, 5-year CAGR — (10.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NGNE OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 10.64 12.39 4.97
Net debt to EBITDA 2.57 1.37 1.01

Dividend

Metric NGNE OVID Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NGNE OVID Biotechnology median
Market cap 513.29m 503.87m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack